OxyContin is the brand name for a time-released opioid painkiller manufactured by Purdue Pharma. It was approved by the U.S. Food and Drug Administration (FDA) in 1995 and marketed to consumers beginning in 1996. OxyContin is prescribed for the long-term relief of moderate to severe chronic pain requiring around-the-clock treatment. Some of its therapeutic uses include the treatment of pain from severe injuries, bursitis, dislocation, fractures, neuralgia, arthritis, spinal conditions and cancer. It is not intended for occasional, \u201cas-needed\u201d pain relief. Other brand names in this class include Roxicodone, OxyIR and Percolone.1,2,3 Regardless of the severity of your abuse, OxyContin addiction treatment centers TX offers are one of the best ways to recover. Oxycodone vs OxyContin Addiction Treatment Centers TX The biggest differences between OxyContin and oxycodone, the ingredient in the brand name, are the time-release component, strength and dosing recommendations. Oxycodone is available by itself and in acetaminophen combination medications (e.g. Percocet). It is released immediately after taking the pill, providing pain relief for about four to six hours. Oxycodone is intended for short-term use only (e.g. after oral surgery). Oxycodone is available in 5 mg, 7.5 mg, 10 mg, 15 mg, 20 mg and 30 mg immediate-release tablets manufactured by several companies. Oxycodone hydrochloride oral solutions are available in 5 mg and 100 mg strengths. The latter strength is only intended for people who are opioid tolerant and suffering from severe chronic pain (e.g. cancer-related).4 No matter what form of prescription drug abuse you suffer from, we can help. OxyContin has stronger effects because it contains a pure concentration of oxycodone, with pain relief lasting up to 12 hours. OxyContin is available in 10 mg, 15 mg, 20 mg, 30 mg, 40 mg, 60 mg and 80 mg extended-release tablets. A 160 mg tablet available in 2000 was suspended in May 2001 due to its severe abuse potential.4 In April 2016, a twice-daily abuse-deterrent oxycodone medication called Xtampza ER received final approval from the FDA. It is prescribed for the management of chronic pain requiring daily, around-the-clock, long-term opioid treatment for which alternative treatment options are inadequate.5 OxyContin Abuse and OxyContin Addiction Treatment TX As soon as it was released, Purdue Pharma hailed OxyContin as the latest and greatest \u201cmiracle pill\u201d for pain sufferers. Drug company representatives told physicians and consumers that OxyContin was safer than other narcotics because it was time-released, so there was essentially no potential for abuse. Shortly after OxyContin hit the market, reports of illicit use and abuse began to increase. Due to the insatiable demand for the drug, some individuals with legal prescriptions started selling OxyContin tablets to drug dealers for a profit. Heroin addicts and other drug users discovered that by crushing OxyContin tablets, they could get a much higher dose of the opioid medication. This resulted in a more powerful high than that of traditional fast-acting narcotic medications, and some even compared it to a heroin high.\u00a0Research has since revealed the rise of addictive prescription drugs such as OxyContin are largely to blame for the recent heroin epidemic\u00a0and increase in heroin-related overdoses.6,7 In 2010, in an attempt to decrease epidemic levels of abuse, Purdue reformulated OxyContin into an abuse-deterrent pill which contains polymer, supposedly making it harder to crush, snort or inject. About 25% of users claim they have figured out how to defeat the deterrent. The FDA approved new labeling describing the abuse-deterrent features and subsequently denied applications from other oxycodone extended-release formulations without abuse-deterrent features. The patent for \u201cOxy 2.0\u201d is good through 2025.6 In 2007, Purdue and its top executives paid more than $600 million in fines for misrepresenting the addiction risks of OxyContin. Purdue has been sued hundreds of times during the last 20 years in regard to its marketing of OxyContin to physicians and the drug\u2019s inherent addiction risk. A lawsuit filed in January 2017 is the first to focus precisely on what the company knew about criminal distribution of the painkiller.6,7 OxyContin abuse is associated with many physical and psychological repercussions requiring the OxyContin addiction treatment centers TX trusts. In higher doses, it can cause respiratory depression, which can be fatal. The precise mechanism of how oxycodone works is the subject of ongoing research, although experts know it binds to specific opioid receptors in the central nervous system thought to play a role in pain-numbing effects. It is theorized oxycodone binds to several different receptors, which may explain why it also causes some unwanted side effects. Due to severe withdrawal symptoms, supervised medical detox programs in Texas\u00a0followed by\u00a0inpatient addiction rehab program\u00a0is the preferred method for treating OxyContin addiction.1,2,3 OxyContin Rehab Centers Texas Stats and Facts \tIn 1996, Purdue Pharma made $45 million in sales from OxyContin alone. By 2001, $200 million spent on marketing efforts yielded $1.1 billion in sales. Ten years later, sales totaled $3.1 billion with OxyContin accounting for about 30% of the total painkiller market.6 \tPrescriptions for OxyContin decreased from 1,608,747 in the second quarter of 2010 to 1,211,593 in the second quarter of 2015.8 \tIn a retrospective analysis of people discharged from emergency departments for pain-related issues, oxycodone was the most widely prescribed pain reliever, accounting for 52.3% of total dispensed drugs. Of those, 97.9% were for the 5-mg pill.9 \tAn estimated 70% to 80% of heroin addicts started by using prescription opioids. Currently, one OxyContin pill may cost $20 to $80, whereas a bag of heroin resulting in the same high can cost as little as $5.10 \tFrom 1997 to 2012, hospitalizations attributed to opioid poisonings increased nearly twofold in the pediatric population. In children ages 1 to 4, the increase was 205%; in adolescents ages 15 to 19, the increase was 176%.11 \tIn 2016, 0.90% of eighth-graders, 2.10% of 10th-graders and 3.40% of 12-graders were past-year users of OxyContin.12 Relapse Prevention from OxyContin Addiction Treatment Centers TX Offers Clients are slowly weaned off opioid painkillers and other addictive drugs. For people with chronic pain, treatments such as acupuncture, medical massage, water\/pool therapy and yoga can reduce pain.6Exercise and other forms of therapy are also helpful for people in recovery for other forms of prescription drug abuse. Long-term management by a team of multidisciplinary providers is the key to addressing ongoing pain through long term relapse prevention programs in Texas. \tHow does OxyContin work? Addiction Blog website.\u00a0https:\/\/prescription-drug.addictionblog.org\/how-does-oxycontin-work\/\u00a0Published June 7, 2012. Accessed February 14, 2017. \tDrugs website.\u00a0https:\/\/www.drugs.com\/oxycontin.html\u00a0Updated February 6, 2017. Accessed February 14, 2017. \tCenter for Substance Abuse Research.\u00a0https:\/\/www.cesar.umd.edu\/cesar\/drugs\/oxycodone.asp\u00a0October 29, 2013. Accessed February 14, 2017. \tOxycodone vs. OxyContin. Healthline website.\u00a0https:\/\/www.healthline.com\/health\/pain-relief\/oxycodone-vs-oxycontin#Overview1\u00a0Published May 23, 2016. Accessed February 14, 2017. \tFDA Gives Final Approval to Abuse-Deterrent Xtampza ER. Medscape website.\u00a0https:\/\/www.medscape.com\/viewarticle\/862662\u00a0Published April 29, 2016. Accessed February 14, 2017. \tHow OxyContin Became the Most Dangerous and Hottest Selling Narcotic in History. Dr. Mercola website.\u00a0https:\/\/articles.mercola.com\/sites\/articles\/archive\/2015\/07\/18\/oxycontin-addiction.aspx\u00a0Published July 18, 2015. Accessed February 14, 2017. \tHarriet Ryan. City devastated by OxyContin use sues Purdue Pharma, claims drugmaker put profits over citizens\u2019 welfare.\u00a0Los Angeles Times. January 19, 2017.\u00a0https:\/\/www.latimes.com\/local\/lanow\/la-me-oxycontin-lawsuit-20170118-story.html\u00a0Accessed February 14, 2017. \tSevertson SG, Ellis MS, Kurtz SP, et al. Sustained reduction of diversion and abuse after introduction of an abuse deterrent formulation of extended release oxycodone.\u00a0Drug Alcohol Depend.\u00a02016 Nov 1;168:219-229. doi: 10.1016\/j.drugalcdep.2016.09.018. \tHoppe JA, Nelson LS, Perrone J, et al. Opioid Prescribing in a Cross Section of U.S. Emergency Departments: The Prescribing Opioids Safely in the Emergency Department (POSED) Study Consortium.\u00a0Ann Emerg Med. 2015;66(3):253-259.e1. doi:10.1016\/j.annemergmed.2015.03.026. \tMolly Triffin. Hospitalizations Among Teens for Opioid Poisonings Increase, Study Shows.\u00a0Teen Vogue. February 13, 2017.\u00a0https:\/\/www.teenvogue.com\/story\/teens-opioid-poisonings-painkillers-hospitalizations-teen-storyAccessed February 14, 2017. \tGaither JR, Leventhal JM, Ryan SA, Camenga DR. National Trends in Hospitalizations for Opioid Poisonings Among Children and Adolescents, 1997 to 2012.\u00a0JAMA Pediatr. 2016;170(12):1195-1201. doi:10.1001\/jamapediatrics.2016.2154. \tNational Institute on Drug Abuse website.\u00a0https:\/\/www.drugabuse.gov\/drugs-abuse\/opioids\u00a0Updated May 2016. Accessed February 14, 2016. Written by The Right Step Editorial Staff Contact our Texas center today for more information on our treatment programs.